Prostate Cancer Market Report 2023: R&D Consistency Drives Sector GrowthPosted by Ganesh Shinde on February 2nd, 2023 The prostate cancer market is anticipated to reach an estimated value of .92 billion globally in 2023 and is anticipated to grow at an estimated CAGR of 8.5% from 2023 to 2033. By 2033, the market is anticipated to reach a value of .7 billion. Exercise can help cancer patients in a variety of ways, including enhancing their quality of life and restoring some of their fundamental functional abilities. Following a prostate cancer diagnosis, physical activity has also been linked to a lower progression rate and longer life times. A recent study shows that even in patients with advanced prostate cancer, a brief period of high-intensity exercise can significantly increase tumor-suppressing responses. In addition to an aging population, the high disposable income also contributes to the market's growth. Growth will also be driven by rising cancer prevalence rates, the changing fashion habits of the population, an increase in patient awareness, and an increase in demand for non-invasive therapies. A number of different methods are available to treat this disease, including targeted or biological therapy, chemotherapy, and hormonal therapy. Further new studies are being approved by the FDA for therapies and drugs that are to be marketed in the near future. There is a recent study conducted by Moon Hyung Choi and co-workers suggests the use of pre-biopsy MRIs can effectively prevent unnecessary biopsies in people who have levels of prostate-specific antigen (PSA) in excess of 20 ng/ml. Key Segments Profiled in the Prostate Cancer Industry Survey Prostate Cancer Market by Drug Class:
Prostate Cancer Market by Distribution Channel:
Read More@ https://www.futuremarketinsights.com/reports/prostate-cancer-market Like it? Share it!More by this author |